Mammalian tissue size is maintained by slow replacement of de-differentiating and dying cells. For adipocytes, key regulators of glucose and lipid metabolism, the renewal rate is only 10% per year. We used computational modeling, quantitative mass spectrometry, and single-cell microscopy to show that cell-to-cell variability, or noise, in protein abundance acts within a network of more than six positive feedbacks to permit pre-adipocytes to differentiate at very low rates. This reconciles two fundamental opposing requirements: High cell-to-cell signal variability is needed to generate very low differentiation rates, whereas low signal variability is needed to prevent differentiated cells from de-differentiating. Higher eukaryotes can thus control low rates of near irreversible cell fate decisions through a balancing act between noise and ultrahigh feedback connectivity.
Abstract-Our objective in work presented here was to understand the mechanisms by which activated p38␣ MAPK depresses myocardial contractility. To test the hypothesis that activation of p38 MAPK directly influences sarcomeric function, we used transgenic mouse models with hearts in which p38 MAPK was constitutively turned on by an upstream activator (MKK6bE). These hearts demonstrated a significant depression in ejection fraction after induction of the transgene. We also studied hearts of mice expressing a dominant negative p38␣ MAPK. Simultaneous determination of tension and ATPase activity of detergent-skinned fiber bundles from left ventricular papillary muscle demonstrated a significant inhibition of both maximum tension and ATPase activity in the transgenic-MKK6bE hearts.Fibers from hearts expressing dominant negative p38␣ MAPK demonstrated no significant change in tension or ATPase activity. There were no significant changes in phosphorylation level of troponin-T3 and troponin-T4, or myosin light chain 2. However, compared with controls, there was a significant depression in levels of phosphorylation of ␣-tropomyosin and troponin I in fiber bundles from transgenic-MKK6bE hearts, but not from dominant negative p38␣ MAPK hearts. Our experiments also showed that p38␣ MAPK colocalizes with ␣-actinin at the Z-disc and complexes with protein phosphatases (PP2␣, PP2). These data are the first to indicate that chronic activation of p38␣ MAPK directly depresses sarcomeric function in association with decreased phosphorylation of ␣-tropomyosin. (Circ Res. 2007;100:408-415.)Key Words: heart failure Ⅲ myofilaments Ⅲ protein phosphatase Ⅲ tropomyosin kinase T he response of the myocardium to stressors that signal hypertrophy, dilation, and failure represents integrated effects of pathways regulating myocyte growth, death, and contractility. 1 A potentially important signaling cascade involves the mitogen activated protein kinase, p38 MAPK. The p38 MAPKs are activated by G-protein coupled receptors, as well as chemical, physical, osmotic, and radiation stresses. 2,3 In vivo studies demonstrated that p38 MAPK activity is increased during hypertrophy induced by pressure overload, and is potentially important in transduction of mechanical signals. 3 Further evidence for p38 MAPK as a stress mediating factor has come from the observation of induction of apoptosis, hypertrophy, and the hypertrophic marker ANF in neonatal cardiac myocytes over-expressing MKK6bE and MKK3bE, the upstream activators of p38 MAPKs. 4,5,6 Activation of p38 MAPK activity in intact hearts also resulted in early lethal cardiomyopathy characterized by impaired contractility. 7 Acute activation of p38 MAPK with arsenite has also been demonstrated to depress tension generated in detergent extracted cardiac myocytes. 8 Moreover, prolonged activation of p38 MAPK activity is also associated with a negative inotropic effect that occurs without alterations in cellular Ca 2ϩ fluxes. 9 Although these studies suggest a general linkage between p38 MAPK activa...
Rationale: p38 is an important stress activated protein kinase involved in gene regulation, proliferation, differentiation, and cell death regulation in heart. p38 kinase activity can be induced through canonical pathway via upstream kinases or by noncanonical autophosphorylation. The intracellular p38 kinase activity is tightly regulated and maintained at low level under basal condition. The underlying regulatory mechanism for canonical p38 kinase activation is well-studied, but the regulation of noncanonical p38 autophosphorylation remains poorly understood. Objective: We investigated the molecular basis for the regulation of noncanonical p38 autophosphorylation and its potential functional impact in cardiomyocytes. Methods and Results: Using both proteomic and biochemical tools, we established that heat shock protein (Hsp)90-Cdc37 chaperones are part of the p38␣ signaling complex in mammalian cells both in vitro and in vivo. The Hsp90-Cdc37 chaperone complex interacts with p38 via direct binding between p38 and Cdc37. Cdc37 expression is both sufficient and necessary to suppress noncanonical p38 activation via autophosphorylation at either basal state or under TAB1 (TAK1 binding protein-1) induction. In contrast, Cdc37 expression has no impact on p38 activation by canonical upstream kinase MKK3 or oxidative stress. Furthermore, Hsp90 inhibition results in p38 activation via autophosphorylation, and p38 activity contribute to apoptotic cell death induced by Hsp90 inhibition. Conclusion: Our study has revealed a so far uncharacterized function of Hsp90-Cdc37 as an endogenous regulator of noncanonical p38 activity. (Circ Res. 2010;106:1404-1412.)Key Words: p38 mitogen-activated protein kinase Ⅲ noncanonical pathway Ⅲ Hsp90 Ⅲ Cdc37 Ⅲ autophosphorylation O xidative stress, proinflammatory cytokines and many other extracellular stimuli activate intracellular stress responses through stress signaling pathways, including SAPK (stress-activated protein kinase) p38 as a member of the mitogen-activated protein kinase (MAPK) superfamily. [1][2][3][4][5] Although the role of p38 in heart remains controversial, activation of p38 in response to ischemia/reperfusion has been demonstrated repetitively. Several findings suggest p38␣ contributes to myocyte cell death by promoting production of proinflammatory cytokines including tumor necrosis factor (TNF)␣, interleukin (IL)-1, and IL-8. This is also supported by the protective effect of p38-specific inhibitor SB203580 in ischemia. On the other hand, protective effect of p38 through activation of heat shock protein (Hsp)27 has also been suggested. There are 2 modes of p38 activation in ischemia. One is the canonical p38 pathway, which is activated by a cascade of phosphorylation through upstream MEKKs (MAPK/extracellular-activated kinase kinases) such as Ask1, 6 and MAPK kinase (MKK)3, -4, or -6, leading to phosphorylation of the TGY motif within the p38 activation loop. 3,4,7 In addition, noncanonical MKK-independent activation of p38 has been demonstrated through intrinsic au...
Three major MAP kinase signaling cascades, ERK, p38, and JNK, play significant roles in the development of cardiac hypertrophy and heart failure in response to external stress and neural/hormonal stimuli. To study the specific function of each MAP kinase branch in adult heart, we have generated three transgenic mouse models with cardiac-specific and temporally regulated expression of activated mutants of Ras, MAP kinase kinase (MKK)3, and MKK7, which are selective upstream activators for ERK, p38, and JNK, respectively. Gene expression profiles in transgenic adult hearts were determined using cDNA microarrays at both early (4-7 days) and late (2-4 wk) time points following transgene induction. From this study, we revealed common changes in gene expression among the three models, particularly involving extracellular matrix remodeling. However, distinct expression patterns characteristic for each pathway were also identified in cell signaling, growth, and physiology. In addition, genes with dynamic expression differences between early vs. late stages illustrated primary vs. secondary changes on MAP kinase activation in adult hearts. These results provide an overview to both short-term and long-term effects of MAP kinase activation in heart and support some common as well as unique roles for each MAP kinase cascade in the development of heart failure.
The protein phosphatase 1-like gene (PPM1l) was identified as causal gene for obesity and metabolic abnormalities in mice. However, the underlying mechanisms were unknown. In this report, we find PPM1l encodes an endoplasmic reticulum (ER) membrane targeted protein phosphatase (PP2Ce) and has specific activity to basal and ER stress induced auto-phosphorylation of Inositol-REquiring protein-1 (IRE1). PP2Ce inactivation resulted in elevated IRE1 phosphorylation and higher expression of XBP-1, CHOP, and BiP at basal. However, ER stress stimulated XBP-1 and BiP induction was blunted while CHOP induction was further enhanced in PP2Ce null cells. PP2Ce protein levels are significantly induced during adipogenesis in vitro and are necessary for normal adipocyte maturation. Finally, we provide evidence that common genetic variation of PPM11 gene is significantly associated with human lipid profile. Therefore, PPM1l mediated IRE1 regulation and downstream ER stress signaling is a plausible molecular basis for its role in metabolic regulation and disorder.
Background: IRE1␣ regulation in ER stress response and protein homeostasis need to be fully studied. Results: IRE1␣ binds the Cdc37-Hsp90 complex. Interfering this interaction enhanced basal IRE1␣ activity and impaired insulin synthesis in INS-1 cells. Conclusion: Negative regulation of IRE1␣ activity by Hsp90/Cdc37 is important for insulin synthesis. Significance: Hsp90/Cdc37-mediated regulation of IRE1␣ adds new mechanistic insight to ER stress signal and regulation.
We recently reported that the PPM1l gene encodes an endoplasmic reticulum (ER) membrane targeted protein phosphatase (named PP2Ce) with highly specific activity towards Inositol-requiring protein-1 (IRE1) and regulates the functional outcome of ER stress. In the present report, we found that the PP2Ce protein is highly expressed in lactating epithelium of the mammary gland. Loss of PP2Ce in vivo impairs physiological unfolded protein response (UPR) and induces stress kinase activation, resulting in loss of milk production and induction of epithelial apoptosis in the lactating mammary gland. This study provides the first in vivo evidence that PP2Ce is an essential regulator of normal lactation, possibly involving IRE1 signaling and ER stress regulation in mammary epithelium.
Insulin resistance (IR) underlies metabolic disease. Visceral, but not subcutaneous, white adipose tissue (WAT) has been linked to the development of IR, potentially due to differences in regulatory protein abundance. Here we investigate how protein levels are changed in IR in different WAT depots by developing a targeted proteomics approach to quantitatively compare the abundance of 42 nuclear proteins in subcutaneous and visceral WAT from a commonly used insulin-resistant mouse model, Lepr(db/db), and from C57BL/6J control mice. The most differentially expressed proteins were important in adipogenesis, as confirmed by siRNA-mediated depletion experiments, suggesting a defect in adipogenesis in visceral, but not subcutaneous, insulin-resistant WAT. Furthermore, differentiation of visceral, but not subcutaneous, insulin-resistant stromal vascular cells (SVCs) was impaired. In an in vitro approach to understand the cause of this impaired differentiation, we compared insulin-resistant visceral SVCs to preadipocyte cell culture models made insulin resistant by different stimuli. The insulin-resistant visceral SVC protein abundance profile correlated most with preadipocyte cell culture cells treated with both palmitate and TNFα. Together, our study introduces a method to simultaneously measure and quantitatively compare nuclear protein expression patterns in primary adipose tissue and adipocyte cell cultures, which we show can reveal relationships between differentiation and disease states of different adipocyte tissue types.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.